The Patent Trial and Appeal Board (PTAB) has upheld Medtronic’s patents concerning a sacral stimulation system. This decision follows an order from the Federal Circuit judges last year, which instructed the PTAB to re-evaluate the arguments presented by the manufacturer of a competing bladder and bowel control device. The rival company was given another opportunity to challenge Medtronic’s patents, but the PTAB’s recent ruling maintains the validity of Medtronic’s intellectual property.
For further details, you can read the [Law360 article](https://www.law360.com/articles/1842938/ptab-upholds-medtronic-bladder-control-patents-on-remand) by Andrew Karpan.